Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype. Sciurba FC, Criner GJ, Christenson SA, Martinez FJ, et al. N Engl J Med 2025;392:1710-1720.

Read + Share

Amedeo Smart

Independent Medical Education

Sciurba FC, Criner GJ, Christenson SA, Martinez FJ, et al. Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype. N Engl J Med 2025;392:1710-1720.
PMID: 40305712